MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
SLM:000511484 slm:000511484 QPZFDQQMQAQERO-VFNZAEPZSA-L | Cardiolipin (16:0/18:1(11Z)/18:1(9Z)/16:0) 1'-[1-hexadecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phospho],3'-[1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho]-glycerol CL (16:0/18:1(11Z)/18:1(9Z)/16:0) |
| hmdb:HMDB0056605 QPZFDQQMQAQERO-VFNZAEPZSA-N | CL(16:0/18:1(11Z)/18:1(9Z)/16:0) 1'-[1-Hexadecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phospho],3'-[1,2-di(9Z-octadecenoyl)-rac-glycero-3-phospho]-glycerol 1'-[1-Palmitoyl-2-vaccenoyl-sn-glycero-3-phospho],3'-[1,2-dioleoyl-rac-glycero-3-phospho]-glycerol 3-{[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propoxy(hydroxy)phosphoryl]oxy}-2-hydroxypropoxy((2R)-2-(hexadecanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propoxy)phosphinic acid CL(1'-[16:0/18:1(11Z)],3'-[18:1(9Z)/18:1(9Z)]) CL(16:0/18:1/18:1/18:1) CL(70:3) Cardiolipin(16:0/18:1/18:1/18:1) Cardiolipin(70:3) [3-({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy][(2R)-2-(hexadecanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid |
hmdb:HMDB56605 | secondary/obsolete/fantasy identifier |